Targeted Medical Pharma Inc (TRGM) Financial Statements (2024 and earlier)

Company Profile

Business Address 2980 BEVERLY GLEN CIRCLE
LOS ANGELES, CA 90077
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12492327
Cash and cash equivalents12492327
Receivables203269354
Inventory, net of allowances, customer advances and progress billings127596478
Inventory127596478
Prepaid expense  901
Prepaid expense and other current assets212
Other current assets192372
Other undisclosed current assets   1,228
Total current assets:5342,6302,599
Noncurrent Assets
Property, plant and equipment107236340
Long-term investments and receivables   (386)
Due from related parties   (386)
Intangible assets, net (including goodwill)1,8592,1332,319
Intangible assets, net (excluding goodwill)1,8592,1332,319
Prepaid expense and other noncurrent assets27
Other undisclosed noncurrent assets   6,877
Total noncurrent assets:1,9662,3689,177
TOTAL ASSETS:2,5004,99811,775
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,7319,7207,024
Employee-related liabilities 3,9972,568 
Accounts payable1,4601,497 
Accounts payable and other accrued liabilities 7,024
Accrued liabilities7,2745,655 
Debt1,0931,458 
Derivative instruments and hedges, liabilities1829 
Deferred tax liabilities   70
Due to related parties2,504 5,033
Other undisclosed current liabilities (3,997)53188
Total current liabilities:12,35011,26112,315
Noncurrent Liabilities
Long-term debt and lease obligation122755 
Long-term debt, excluding current maturities122755 
Liabilities, other than long-term debt  1,463
Deferred tax liabilities, net   1,077
Due to related parties  386
Total noncurrent liabilities:1227551,463
Total liabilities:12,47212,01513,777
Equity
Equity, attributable to parent, including:(9,972)(7,018)(2,002)
Common stock272623
Additional paid in capital16,91915,97911,660
Accumulated deficit(26,917)(23,022)(13,685)
Warrants and rights outstanding   188
Other undisclosed equity, attributable to parent   (188)
Equity, attributable to noncontrolling interest   
Total equity:(9,972)(7,018)(2,002)
TOTAL LIABILITIES AND EQUITY:2,5004,99811,775

Income Statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
7,1129,5567,296
Cost of revenue
(Cost of Goods and Services Sold)
(2,217)(2,989)(3,201)
Gross profit:4,8966,5664,095
Operating expenses(7,507)(10,407)(10,235)
Operating loss:(2,611)(3,841)(6,140)
Nonoperating income (expense)(1,218)170(6,632)
Interest and debt expense 11(215)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes (11)215
Loss from continuing operations before equity method investments, income taxes:(3,829)(3,671)(12,772)
Income from equity method investments 734  
Loss from continuing operations before income taxes:(3,095)(3,671)(12,772)
Income tax expense (benefit) (66)(5,667)3,186
Loss from continuing operations:(3,161)(9,338)(9,586)
Loss before gain (loss) on sale of properties:(3,161)(9,338)(9,586)
Net loss:(3,161)(9,338)(9,586)
Net income attributable to noncontrolling interest   
Other undisclosed net loss attributable to parent (734)  
Net loss available to common stockholders, diluted:(3,895)(9,338)(9,586)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(3,161)(9,338)(9,586)
Comprehensive loss:(3,161)(9,338)(9,586)
Comprehensive income, net of tax, attributable to noncontrolling interest   
Comprehensive loss, net of tax, attributable to parent:(3,161)(9,338)(9,586)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: